BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28750340)

  • 1. Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.
    Yoo E; Cheng HA; Nardacci LE; Beaman DJ; Drinnan CT; Lee C; Fishbein KW; Spencer RG; Fisher OZ; Doiron AL
    Colloids Surf B Biointerfaces; 2017 Oct; 158():578-588. PubMed ID: 28750340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
    Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
    Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies.
    Feng ST; Li H; Luo Y; Cai H; Dong Z; Fang Z; Shuai X; Li ZP
    Curr Cancer Drug Targets; 2016; 16(6):551-60. PubMed ID: 27262319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.
    Roohi F; Lohrke J; Ide A; Schütz G; Dassler K
    Int J Nanomedicine; 2012; 7():4447-58. PubMed ID: 22927759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of Targeting Biomolecule Improves Interpolymer Complex-Superparamagnetic Iron Oxide Nanoparticles Attachment to and Activation of T
    Nwasike C; Purr E; Nagi JS; Mahler GJ; Doiron AL
    Int J Nanomedicine; 2023; 18():473-487. PubMed ID: 36718192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How morphology influences relaxivity - comparative study of superparamagnetic iron oxide-polymer hybrid nanostructures.
    Ebert S; Bannwarth MB; Musyanovych A; Landfester K; Münnemann K
    Contrast Media Mol Imaging; 2015; 10(6):456-64. PubMed ID: 26153149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
    Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
    Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
    Tähkä S; Laiho A; Kostiainen MA
    Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
    Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
    Amstad E; Zurcher S; Mashaghi A; Wong JY; Textor M; Reimhult E
    Small; 2009 Jun; 5(11):1334-42. PubMed ID: 19242944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional reduction-responsive SPIO&DOX-loaded PEGylated polymeric lipid vesicles for magnetic resonance imaging-guided drug delivery.
    Wang S; Yang W; Du H; Guo F; Wang H; Chang J; Gong X; Zhang B
    Nanotechnology; 2016 Apr; 27(16):165101. PubMed ID: 26941226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial Organization of Superparamagnetic Iron Oxide Nanoparticles in/on Nano/Microsized Carriers Modulates the Magnetic Resonance Signal.
    Lee MK; Clay NE; Ko E; Smith CE; Chen L; Cho N; Sung HJ; DiPietro L; Lee J; Kong H
    Langmuir; 2018 Dec; 34(50):15276-15282. PubMed ID: 30458616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
    Chen YC; Chang WH; Wang SJ; Hsieh WY
    J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
    Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent.
    Deng LH; Jiang H; Lu FL; Wang HW; Pu Y; Wu CQ; Tang HJ; Xu Y; Chen TW; Zhu J; Shen CY; Zhang XM
    Int J Nanomedicine; 2021; 16():201-211. PubMed ID: 33447035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent.
    Masoudi A; Madaah Hosseini HR; Shokrgozar MA; Ahmadi R; Oghabian MA
    Int J Pharm; 2012 Aug; 433(1-2):129-41. PubMed ID: 22579990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity.
    Tong S; Hou S; Zheng Z; Zhou J; Bao G
    Nano Lett; 2010 Nov; 10(11):4607-13. PubMed ID: 20939602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
    Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
    Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.